financetom
Business
financetom
/
Business
/
Wolfspeed (WOLF) Stock Is Exploding Higher Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wolfspeed (WOLF) Stock Is Exploding Higher Monday: What's Going On?
Jul 7, 2025 9:35 AM

Wolfspeed Inc ( WOLF ) shares are trading sharply higher Monday morning. The company announced the appointment of Gregor van Issum as its new Executive Vice President and Chief Financial Officer, effective September 1.

What To Know: Van Issum, a seasoned semiconductor executive from ams-OSRAM, will take the financial helm as the company navigates a major strategic overhaul.

The leadership change comes just one week after Wolfspeed ( WOLF ) initiated a pre-packaged Chapter 11 filing to fortify its financial standing. The restructuring plan, supported by a majority of its lenders, is set to slash debt by approximately $4.6 billion and cut annual cash interest payments by 60%.

Investors responded favorably to the restructuring news last week, sending the company's stock soaring 170% on a weekly basis. The appointment of a new CFO is seen as a critical step in steering the silicon carbide leader toward its goal of accelerated profitability. Van Issum will succeed interim CFO Kevin Speirits, who will resume his prior role.

CEO Robert Feurle has stated the restructuring will better position Wolfspeed ( WOLF ) to meet growing market demands. With new financial leadership in place, the company remains on track to emerge from Chapter 11 by the end of the third quarter while continuing normal operations.

Price Action: According to data from Benzinga Pro, WOLF shares are trading higher by 106.8% to $2.44 Monday morning. The stock is also higher by some 380% over the trailing week. WOLF has a 52-week high of $25.49 and a 52-week low of $0.39.

Read Also: Why Wolfspeed Stock Is Extremely Volatile Today

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved